scholarly journals International Myeloma Working Group response criteria

2019 ◽  
Author(s):  
Patrick Rock ◽  
Francis Deng
Keyword(s):  
Working Group ◽  
Response Criteria ◽  
Group Response ◽  
International Myeloma Working Group

Quantification of bone-marrow plasma cell levels using various International Myeloma Working Group response criteria in patients with multiple myeloma

2018 ◽  
Vol 108 (4) ◽  
pp. 371-374 ◽  
Author(s):  
Kentaro Narita ◽  
Hiroki Kobayashi ◽  
Yoshiaki Abe ◽  
Hiroaki Kitadate ◽  
Masami Takeuchi ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Bone Marrow ◽  
Plasma Cell ◽  
Working Group ◽  
Response Criteria ◽  
Group Response ◽  
Bone Marrow Plasma ◽  
International Myeloma Working Group

scholarly journals Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium

2020 ◽  
Author(s):  
Rami S. Komrokji ◽  
Najla H Al Ali ◽  
David Sallman ◽  
Eric Padron ◽  
Amy E. DeZern ◽  
...  
Keyword(s):  
Clinical Research ◽  
Myelodysplastic Syndromes ◽  
Working Group ◽  
Response Criteria ◽  
International Working Group ◽  
Group Response ◽  
Research Consortium

Agreement study between the response criteria of the international Myeloma Working Group vs the Intergroupe Francophone du Myelome

2019 ◽  
Vol 493 ◽  
pp. S420-S421
Author(s):  
D. Melero López ◽  
I. Liria González ◽  
N.M. Barbosa De Carvalho ◽  
C. Tejedor Díaz ◽  
P. Puerta Fonollá
Keyword(s):  
Working Group ◽  
Response Criteria ◽  
Agreement Study ◽  
International Myeloma Working Group

scholarly journals Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

Leukemia ◽  
2012 ◽  
Vol 27 (4) ◽  
pp. 780-791 ◽  
Author(s):  
C Fernández de Larrea ◽  
◽  
R A Kyle ◽  
B G M Durie ◽  
H Ludwig ◽  
...  
Keyword(s):  
Plasma Cell ◽  
Working Group ◽  
Consensus Statement ◽  
Treatment Recommendations ◽  
Plasma Cell Leukemia ◽  
Response Criteria ◽  
Cell Leukemia ◽  
International Myeloma Working Group

scholarly journals Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

Blood ◽  
2015 ◽  
Vol 125 (13) ◽  
pp. 2068-2074 ◽  
Author(s):  
Antonio Palumbo ◽  
Sara Bringhen ◽  
Maria-Victoria Mateos ◽  
Alessandra Larocca ◽  
Thierry Facon ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Geriatric Assessment ◽  
Working Group ◽  
Key Points ◽  
Group Report ◽  
Assessment Strategies ◽  
International Myeloma Working Group ◽  
Frailty Score

Key Points Elderly patients with myeloma are heterogeneous and assessment strategies are needed to define the frailty profile. The proposed frailty score aims to better assess patients and provide them with more suitable therapies.

scholarly journals Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

Blood ◽  
2019 ◽  
Vol 133 (10) ◽  
pp. 1020-1030 ◽  
Author(s):  
U. Platzbecker ◽  
P. Fenaux ◽  
L. Adès ◽  
A. Giagounidis ◽  
V. Santini ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Myelodysplastic Syndromes ◽  
Working Group ◽  
Lower Risk ◽  
Response Assessment ◽  
Response To Treatment ◽  
Response Criteria ◽  
Patient Response ◽  
Erythroid Response ◽  
Clinical Responses

Abstract The heterogeneity of myelodysplastic syndromes (MDSs) has made evaluating patient response to treatment challenging. In 2006, the International Working Group (IWG) proposed a revision to previously published standardized response criteria (IWG 2000) for uniformly evaluating clinical responses in MDSs. These IWG 2006 criteria have been used prospectively in many clinical trials in MDSs, but proved challenging in several of them, especially for the evaluation of erythroid response. In this report, we provide rationale for modifications (IWG 2018) of these recommendations, mainly for “hematological improvement” criteria used for lower-risk MDSs, based on recent practical and reported experience in clinical trials. Most suggestions relate to erythroid response assessment, which are refined in an overall more stringent manner. Two major proposed changes are the differentiation between “procedures” and “criteria” for hematologic improvement–erythroid assessment and a new categorization of transfusion-burden subgroups.

Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older

2019 ◽  
Vol 10 (3) ◽  
pp. 486-489 ◽  
Author(s):  
Anays Murillo ◽  
Angel M. Cronin ◽  
Jacob P. Laubach ◽  
Tammy T. Hshieh ◽  
Anna M. Tanasijevic ◽  
...  
Keyword(s):  
Working Group ◽  
International Myeloma Working Group ◽  
Frailty Score
Sign in / Sign up

Export Citation Format

Share Document